Man Group PLC Puma Biotechnology, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Man Group PLC holds 117,665 shares of PBYI stock, worth $349,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,665

Previous 211,682 44.41%

Holding current value

$349,465

Previous $1.12 Million 65.83%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.83 $274,529 - $548,119	-94,017 Reduced 44.41%	117,665 $383,000
Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $184,349 - $317,992	42,972 Added 25.47%	211,682 $1.12 Million
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $376,223 - $757,507	168,710 New	168,710 $730,000
Q1 2023 May 15, 2023	BUY	$2.21 - $4.82 $32,506 - $70,897	14,709 Added 30.8%	62,458 $192,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $58,444 - $140,045	27,568 Added 136.6%	47,749 $201,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $2,304 - $3,897	1,015 Added 5.3%	20,181 $48,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $101,081 - $203,395	-61,635 Reduced 76.28%	19,166 $55,000
Q1 2022 May 16, 2022	BUY	$2.13 - $3.24 $53,037 - $80,676	24,900 Added 44.54%	80,801 $233,000
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $96,047 - $221,752	33,701 Added 151.81%	55,901 $170,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $147,186 - $208,458	22,200 New	22,200 $156,000
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $265,562 - $414,045	-34,134 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $58,900 - $69,068	-6,200 Reduced 15.37%	34,134 $344,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $43,462 - $82,088	6,200 Added 18.16%	40,334 $421,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $103,199 - $239,428	-16,433 Reduced 32.5%	34,134 $288,000
Q4 2019 Feb 18, 2020	BUY	$6.5 - $10.73 $328,685 - $542,583	50,567 New	50,567 $442,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $157,750 - $367,062	-7,860 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $323,832 - $470,421	7,860 New	7,860 $360,000

Others Institutions Holding PBYI

# of Institutions

Shares Held

29.3M

Call Options Held

73.5K

Put Options Held

18.5K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account